Sex differences in clinical characteristics and long‐term clinical outcomes in Asian hospitalized heart failure patients

Abstract

AbstractAimsSex differences in long‐term post‐discharge clinical outcomes in Asian patients hospitalized for acute decompensated heart failure (HF) persist despite the world‐wide implementation of guideline‐directed medical therapy for decades. The present study aims to elucidate the puzzling dilemma and to depict the directions of solution.Methods and resultsBetween 2011 and 2020, a total of 12 428 patients (6518 men and 5910 women, mean age 73.50 ± 14.85) hospitalized for acute decompensated HF were retrospectively enrolled from a university HF cohort. Compared with men, women hospitalized for acute decompensated HF were older in age (76.40 ± 13.43 vs. 71.20 ± 15.67 years old, P < 0.0001) with more coexisting hypertension, diabetes, hyperlipidaemia and moderate to severe chronic kidney disease, but less with ischaemic heart disease, cerebrovascular disease and chronic obstructive pulmonary disease (P < 0.0001). In echocardiography measurement parameters, women had smaller left ventricular and left atrial dimensions, higher left ventricular mass index, higher left ventricular ejection fraction (LVEF) and more in HF with preserved ejection fraction (EF) category (LVEF > 50%) than men (P < 0.0001). In HF therapy, women compared with men received more guideline‐directed medical HF therapies including angiotensin‐converting enzyme inhibitors, angiotensin receptor blockers, angiotensin receptor–neprilysin inhibitors and sodium–glucose cotransporter‐2 inhibitors, but similar beta‐blockers and mineralocorticoid receptor antagonists (P < 0.0001). Post‐discharge long‐term clinical outcomes after multivariate‐adjusted analysis revealed that women compared with men had lower all‐cause mortality [adjusted hazard ratio (aHR): 0.89, 95% confidence interval (CI): 0.84–0.93], lower cardiovascular mortality (aHR: 0.89, 95% CI: 0.80–0.99) and lower 1 year mortality (aHR: 0.91, 95% CI: 0.84–0.99) but similar HF rehospitalization rate (aHR: 1.02, 95% CI: 0.95–1.09) over 8 years of follow‐up. The superiority of women over men in all‐cause mortality was shown in HF with preserved EF (>50%) and HF with mildly reduced EF (40%–50%), but not in HF with reduced EF (<40%) category. Subgroup forest plot analysis showed body mass index, coexisting hypertension and chronic obstructive pulmonary disease as significant interacting factors.ConclusionsWith more coronary risk factors and medical comorbidities, less cardiac remodelling and better adherence to guideline‐directed HF therapy, women hospitalized for acute decompensated HF demonstrated superiority over men in long‐term post‐discharge clinical outcomes, including all‐cause mortality, cardiovascular mortality and 1 year mortality, and mainly in HF with preserved and mid‐range EF categories, in the Asian HF cohort.